Sutro Biopharma Newsroom

Sutro Biopharma Analyst Ratings

Benzinga12:14 ET

Truist Financial Maintains Sutro Biopharma(STRO.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsAug 16 07:32 ET

Truist Financial Sticks to Their Buy Rating for Sutro Biopharma (STRO)

TipRanksAug 16 07:18 ET

A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $8 to $17

Moomoo NewsAug 15 09:00 ET

Sutro Biopharma's Strong Financials and Clinical Progress Reinforce Buy Rating

TipRanksAug 15 00:37 ET

A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $5 to $12

Moomoo NewsAug 14 09:00 ET

Wedbush Sticks to Its Buy Rating for Sutro Biopharma (STRO)

TipRanksAug 14 08:18 ET

Sutro Biopharma Analyst Ratings

BenzingaAug 14 07:06 ET

Sutro Biopharma: A Stable Hold Amidst Anticipated Trial Updates and Market Perceptions

TipRanksAug 14 06:48 ET

Buy Rating Affirmed for Sutro Biopharma on Promising Luvelta and Bevacizumab Combination Therapy

TipRanksAug 14 06:48 ET

TD Cowen Reaffirms Their Buy Rating on Sutro Biopharma (STRO)

TipRanksAug 13 18:40 ET

Bank of America Securities Sticks to Its Buy Rating for Sutro Biopharma (STRO)

TipRanksMay 24 08:50 ET

Sutro Biopharma (STRO) Gets a Hold From Wells Fargo

TipRanksMay 16 05:46 ET

Analysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Athira Pharma (ATHA) and Taysha Gene Therapies (TSHA)

TipRanksMay 16 00:35 ET

Sutro Biopharma Analyst Ratings

BenzingaMay 15 11:37 ET

Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target

BenzingaMay 15 11:36 ET

Oppenheimer Sticks to Their Buy Rating for Sutro Biopharma (STRO)

TipRanksMay 15 07:51 ET

Sutro Biopharma Analyst Ratings

BenzingaMay 14 07:20 ET

Buy Rating on Sutro Biopharma: Promising Trials and Market Expansion Potential for Luvelta

TipRanksMay 14 06:25 ET

Sutro Biopharma Analyst Ratings

BenzingaMay 8 06:17 ET